Long term efficacy and safety of patients with Ankylosing spondylitis treated with etanercept for 5 years: Analysis of different types of response

被引:0
|
作者
Baraliakos, Xenofon [1 ]
Listing, J. [2 ]
Fritz, C. [2 ]
Song, In-Ho [3 ]
Haibel, H. [3 ]
Heldmann, F. [1 ]
Rudwaleit, M. [3 ]
Sieper, J. [3 ]
Braun, Juergen [1 ]
机构
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Charite, Berlin, Germany
来源
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S357 / S357
页数:1
相关论文
共 50 条
  • [41] Safety and efficacy of discontinuation and re-administration of infliximab after long term continuous therapy in patients with ankylosing spondylitis
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A44 - A44
  • [42] Radiographic results from a long-term multicenter trial of etanercept ENBREL®) in patients with Ankylosing Spondylitis.
    Dijkmans, B
    Wanders, A
    van der Heijde, D
    Fatenejad, S
    Afdeling, R
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S634 - S634
  • [43] A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
    Anna Rita Giardina
    Angelo Ferrante
    Francesco Ciccia
    Rosalia Impastato
    Maria Concetta Miceli
    Alfonso Principato
    Giovanni Triolo
    Rheumatology International, 2010, 30 : 1437 - 1440
  • [44] Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis
    Chou, Chung-Tei
    Tsai, Chang-Youh
    Liang, Tung-Hua
    Chang, Te-Ming
    Lai, Chen-Hung
    Wei, Cheng-Chung
    Chen, Kun-Hung
    Lin, Shih-Chang
    Yu, Chia-Li
    Liou, Lieh-Bang
    Luo, Shue-Fen
    Lee, Chyou-Shen
    Hsue, Yin-Tzu
    Huang, Chung-Ming
    Chen, Jiunn-Hong
    Lai, Ning-Sheng
    Cheng, He-Hsiung
    Cheng, Tien-Tsai
    Lai, Han-Ming
    Tsai, Wen-Chan
    Yen, Jeng-Hsien
    Lu, Ling-Ying
    Chang, Chung-Pei
    MODERN RHEUMATOLOGY, 2010, 20 (06) : 580 - 587
  • [45] DRUG SURVIVAL AND CLINICAL EFFICACY OF 7 YEARS ETANERCEPT TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE GLAS COHORT
    Arends, S.
    Brouwer, E.
    Wink, F.
    Bos, R.
    Maas, F.
    Bootsma, H.
    van der Veer, E.
    Spoorenberg, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 283 - 283
  • [46] A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
    Giardina, Anna Rita
    Ferrante, Angelo
    Ciccia, Francesco
    Impastato, Rosalia
    Miceli, Maria Concetta
    Principato, Alfonso
    Triolo, Giovanni
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) : 1437 - 1440
  • [47] Efficacy and safety of ultrasound-guided local injections of etanercept into entheses of ankylosing spondylitis patients with refractory Achilles enthesitis
    Huang, Z.
    Cao, J.
    Li, T.
    Zheng, B.
    Wang, M.
    Zheng, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 642 - 649
  • [48] Clinical response to long-term therapy with infliximab in patients with ankylosing spondylitis -: Results after 3 years.
    Baraliakos, X
    Brandt, J
    Listing, J
    Rudwaleit, M
    Alten, R
    Burmester, A
    Gromnicalhle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S217 - S217
  • [49] Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients
    Druce, Katie L.
    Aikman, Laraine
    Dilleen, Maria
    Burden, Annie
    Szczypa, Piotr
    Basu, Neil
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [50] Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients
    Katie L. Druce
    Laraine Aikman
    Maria Dilleen
    Annie Burden
    Piotr Szczypa
    Neil Basu
    Arthritis Research & Therapy, 20